Systemic barriers to risk-reducing interventions for hereditary cancer syndromes: implications for health care inequities

KF Mittendorf, S Knerr, TL Kauffman… - JCO Precision …, 2021 - ascopubs.org
Hereditary cancer syndromes result from germline genetic alterations predisposing
individuals to higher lifetime cancer risk than the general population. Hereditary cancer …

Risk reduction and survival benefit of risk-reducing salpingo-oophorectomy in hereditary breast cancer: meta-analysis and systematic review

YL Xiao, K Wang, Q Liu, J Li, X Zhang, HY Li - Clinical Breast Cancer, 2019 - Elsevier
Background Objections have been raised to performing risk-reducing salpingo-
oophorectomy (RRSO) to reduce disease incidence and mortality of women with BRCA …

[HTML][HTML] Management strategies of breast cancer patients with BRCA1 and BRCA2 pathogenic germline variants

S Edaily, H Abdel-Razeq - OncoTargets and Therapy, 2022 - ncbi.nlm.nih.gov
Most of breast cancer cases are sporadic; however, 15–20% are associated with family
history, and some are inherited. Among those, deleterious mutations in BRCA1 and BRCA2 …

Differences among a modern cohort of BRCA mutation carriers choosing bilateral prophylactic mastectomies compared to breast surveillance

E Gilbert, EC Zabor, M Stempel, D Mangino… - Annals of surgical …, 2017 - Springer
Background Women with a BRCA mutation have significantly elevated breast cancer risk,
which can be reduced by> 90% with bilateral prophylactic mastectomy (BPM). We sought to …

Influential factors on risk-reduction mastectomy in a high-risk breast cancer population with genetic predispositions

G Wei, A Kumar, MC Lee, X Wang - Clinical Breast Cancer, 2021 - Elsevier
Background Carriers of deleterious mutations in breast cancer predisposition genes are
presented with critical choices regarding cancer risk management. Risk-reduction …

[HTML][HTML] Patient-Reported Outcome Measures may optimize shared decision-making for cancer risk management in BRCA mutation carriers

LSE van Egdom, MA de Kock, I Apon, MAM Mureau… - Breast Cancer, 2020 - Springer
Purpose The aim of this study was to compare patient-reported outcomes (PROs) of
BRCA1/2 mutation carriers, either after bilateral prophylactic mastectomy (BPM) or during …

Information needs of women with BRCA mutations regarding cancer risk management and decision-making

B Anne-Marie, P Manria, H Yvonne… - European Journal of …, 2024 - Elsevier
Providing women who have tested positive for a pathogenic variant in BRCA1 or BRCA 2
relevant information can help them to make informed decisions about managing their cancer …

[HTML][HTML] The breast cancer screening and timing of breast MRI—experience in a genetic high-risk screening clinic in a comprehensive cancer center

X Wang, MD Chang, MC Lee, BL Niell - Current Oncology, 2022 - mdpi.com
For women with genetic risk of breast cancer, the addition of screening breast MRI to
mammography has become a standard. The order and interval of annual imaging can be …

Factors that impact risk management decisions among women with pathogenic variants in moderate penetrance genes associated with hereditary breast cancer

M Napoli, J Lewis, J Hopper… - Journal of Genetic …, 2020 - Wiley Online Library
There is limited information known about how women with pathogenic variants (PV) in
moderate penetrance genes make decisions to manage their increased risk of breast …

Perfil de pacientes con mutación BRCA y cáncer de mama

EM Gómez, FA Velasco, AC Cuetos… - Revista de Senología y …, 2017 - Elsevier
Objetivo Estudiar el perfil de las pacientes con cáncer de mama y mutación BRCA1 o
BRCA2. Material y métodos Se realizó un estudio retrospectivo entre 2010 y 2016 de 28 …